ICCC
#3862
ImmuCell Corporation - Common Stock
10.7 9 USD
+0.12%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+12.40%
Changement Mensuel
+10.67%
Evolution sur 6 mois
+40.13%
Changement Annuel
+66.77%
Clôture Précédente
9.6 0
Open
10.5 0
Low
10.1 5
High
10.8 0
Financials
- Market Capitalization 98 M
- Employee 73
- Founded 1982
- CEO Michael F Brigham
- Website www.immucell.com
- Headquarter Delaware, United States
- FIGI BBG000BLQ5Q2
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-51.25
ratio cours/chiffre d'affaires
2.01
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3846 |  RANI Rani Therapeutics Holdings, Inc. - Class A Common Stock | 0.73 USD | -2.67% | -9.88% | -12.05% | +55.32% | 101.76 M USD | ||
| 3851 |  HUMA Humacyte, Inc. - Common Stock | 0.36 USD | -7.69% | -25.00% | -35.71% | -80.00% | 100.01 M USD | ||
| 3867 |  BDTX Black Diamond Therapeutics, Inc. - Common Stock | 1.68 USD | -5.08% | -6.15% | -16.83% | -55.32% | 96.52 M USD | ||
| 3870 |  MIST Milestone Pharmaceuticals Inc. - Common Shares | 0.77 USD | -4.94% | +1.32% | -20.62% | -62.25% | 95.86 M USD |